Patent · US Active

Compounds for treatment of cancer

US10301285B2 · kind B2 · utility

4Cited by
11References
25Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 21, 2015
Grant dateMay 28, 2019
Priority date
Expiry dateApr 21, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula XXII and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.